The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

ESMO WCGIC 2020 | Changes in the management of bilary tract cancer

Name: Changes in the management of bilary tract cancer
Uploaded: 2020-06-30T00:00:00Z
Duration: 1 min 15 s
Description: Milind Javle, MD, of MD Anderson Cancer Center, Houston, TX, discusses changes in the management in biliary tract cancer, in part due to next-generation sequencing and the identification of actionable mutations. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Milind Javle • 30 Jun 2020

ESMO WCGIC 2020

Bile Duct Cancer Gastrointestinal Cancer Pemigatinib

Milind Javle, MD, of MD Anderson Cancer Center, Houston, TX, discusses changes in the management in biliary tract cancer, in part due to next-generation sequencing and the identification of actionable mutations. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).